The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
UAE responds to incoming missile, drone threats from Iran on Tuesday
Rain forecast for parts of UAE until March 12
H.H. Sheikh Mohammed issues law on building safety in Dubai
UAE leaders highlight unity and strength in Dubai meeting
Sheikh Abdullah reviews impact of Iranian attacks with Cypriot President
UAE modifies alert sounds in National Early Warning System
2 members of UAE Armed Forces martyred in helicopter crash
UAE condemns drone attack on consulate in Iraqi Kurdistan
